Ikarian Capital, LLC Igm Biosciences, Inc. Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$13.27 - $25.5 $21,059 - $40,468	-1,587 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $1,167 - $2,586	87 Added 5.8%	1,587 $43,000
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $1.38 Million - $3.32 Million	-50,000 Reduced 97.09%	1,500 $44,000
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $3.39 Million - $4.67 Million	51,500 New	51,500 $3.39 Million
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $17,394 - $28,980	-300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.41 - $115.03 $14,222 - $34,509	300 New	300 $27,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $214M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.